Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
ConclusionThis case evidences that sequential personalized prescription of different TKIs may show promising efficacy in terms of survival and quality of life in MCC.
Source: Experimental Hematology and Oncology - Category: Cancer & Oncology Source Type: research
More News: Bile Duct Cancer | Cancer & Oncology | Chemotherapy | Cholangiocarcinoma | Genetics | Hematology | Pain | Xeloda